Biologically Active Adrenomedullin (bio-ADM) is of Potential Value in Identifying Congestion and Selecting Patients for Neurohormonal Blockade in Acute Dyspnea

Autor: Simonavičius, Justas, Mikalauskas, Aurimas, Čerlinskaitė, Kamilė, Gayat, Etienne, Juknevičius, Vytautas, Palevičiūtė, Eglė, Alitoit-Marrote, Irina, Kablučko, Denis, Bagdonaitė, Loreta, Balčiūnas, Mindaugas, Vaičiulienė, Dovilė, Jonauskienė, Ieva, Motiejūnaitė, Justina, Stašaitis, Kęstutis, Kukulskis, Audrys, Damalakas, Šarūnas, Šimbelytė, Toma, Taparauskaitė, Neringa, Pukanasienė, Gintarė, Laucevičius, Aleksandras, Kavoliūnienė, Aušra, Mebazaa, Alexandre, Čelutkienė, Jelena

Publikováno v: In The American Journal of Medicine July 2022 135(7):e165-e181

Which clinical findings can be crucial to differentiate pulmonary embolism and acute heart failure in patients presented with acute dyspnea?

Autor: Verikas, Dovydas, Norvilaitė, Rita, Kukulskis, Audrys, Kavoliūnienė, Aušra

Publikováno v: European Heart Journal: Acute Cardiovascular Care 2018: 6th annual congress of the Acute Cardiovascular Care Association : Milan, Italy, 3-5 March, 2018 / ACCA ; Editor-in-Chief Christiaan Vrints, London : SAGE Publishing Ltd, 2018, vol. 7, iss 1, suppl, p. 67-67, no. P155

Introduction: Dyspnea is a common symptom in patients hospitalized with acute cardiopulmonary diseases. Unnecessary diagnostic tests are usually ordered to prove the diagnosis for patients with dyspnea. There is still a lack of knowledge which set of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2888::1e0e7566f3aef75fd5b66dc3a0f45f8b
https://library.lsmuni.lt/LSMU:ELABAPDB28060714&prefLang=en_US